Icon Advisers Inc. Co. Cuts Holdings in Becton Dickinson and Co (BDX)

Icon Advisers Inc. Co. decreased its position in shares of Becton Dickinson and Co (NYSE:BDX) by 42.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,961 shares of the medical instruments supplier’s stock after selling 4,369 shares during the period. Icon Advisers Inc. Co.’s holdings in Becton Dickinson and were worth $1,489,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Oregon Public Employees Retirement Fund lifted its stake in Becton Dickinson and by 22,485.4% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,574,612 shares of the medical instruments supplier’s stock worth $29,000 after purchasing an additional 6,545,502 shares during the last quarter. Ronna Sue Cohen raised its stake in shares of Becton Dickinson and by 24,129.0% during the first quarter. Ronna Sue Cohen now owns 5,734,031 shares of the medical instruments supplier’s stock valued at $5,734,000 after acquiring an additional 5,710,365 shares in the last quarter. Norges Bank bought a new stake in shares of Becton Dickinson and during the fourth quarter valued at approximately $515,703,000. Morgan Stanley raised its stake in shares of Becton Dickinson and by 133.0% during the third quarter. Morgan Stanley now owns 2,771,269 shares of the medical instruments supplier’s stock valued at $723,303,000 after acquiring an additional 1,581,829 shares in the last quarter. Finally, Mackenzie Financial Corp raised its stake in shares of Becton Dickinson and by 27.7% during the fourth quarter. Mackenzie Financial Corp now owns 1,943,752 shares of the medical instruments supplier’s stock valued at $437,966,000 after acquiring an additional 421,825 shares in the last quarter. Hedge funds and other institutional investors own 84.60% of the company’s stock.

In related news, EVP Samrat S. Khichi sold 16,085 shares of the company’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $234.68, for a total transaction of $3,774,827.80. Following the completion of the transaction, the executive vice president now owns 12,608 shares in the company, valued at approximately $2,958,845.44. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Betty D. Larson sold 1,700 shares of the company’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $224.97, for a total transaction of $382,449.00. Following the transaction, the executive vice president now owns 11,493 shares of the company’s stock, valued at approximately $2,585,580.21. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 36,129 shares of company stock valued at $8,836,315. Insiders own 0.12% of the company’s stock.

Several brokerages recently issued reports on BDX. ValuEngine lowered shares of Becton Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, April 1st. Zacks Investment Research raised shares of Becton Dickinson and from a “sell” rating to a “hold” rating in a report on Wednesday, April 10th. Barclays lifted their price target on shares of Becton Dickinson and from $260.00 to $266.00 and gave the stock an “equal weight” rating in a report on Monday, April 15th. Raymond James cut their price target on shares of Becton Dickinson and from $290.00 to $280.00 and set a “strong-buy” rating on the stock in a report on Tuesday, March 19th. Finally, TheStreet raised shares of Becton Dickinson and from a “c+” rating to an “a” rating in a report on Tuesday, February 5th. Six equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Becton Dickinson and currently has a consensus rating of “Buy” and a consensus price target of $255.31.

Shares of Becton Dickinson and stock traded down $0.16 during trading hours on Wednesday, reaching $234.00. The stock had a trading volume of 1,021,179 shares, compared to its average volume of 1,498,131. The company has a market cap of $63.44 billion, a P/E ratio of 21.25, a price-to-earnings-growth ratio of 1.76 and a beta of 1.16. Becton Dickinson and Co has a twelve month low of $208.62 and a twelve month high of $265.87. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.59 and a current ratio of 0.96.

Becton Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.02. The business had revenue of $4.20 billion during the quarter, compared to the consensus estimate of $4.25 billion. Becton Dickinson and had a net margin of 5.88% and a return on equity of 14.58%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.65 earnings per share. Equities research analysts forecast that Becton Dickinson and Co will post 11.69 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 7th will be given a dividend of $0.77 per share. The ex-dividend date is Thursday, June 6th. This represents a $3.08 annualized dividend and a dividend yield of 1.32%. Becton Dickinson and’s dividend payout ratio (DPR) is presently 27.97%.

COPYRIGHT VIOLATION NOTICE: “Icon Advisers Inc. Co. Cuts Holdings in Becton Dickinson and Co (BDX)” was first reported by Sundance Herald and is the sole property of of Sundance Herald. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://sundanceherald.com/2019/05/29/icon-advisers-inc-co-decreases-position-in-becton-dickinson-and-co-bdx.html.

About Becton Dickinson and

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems.

Read More: Understanding Market Liquidity

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply